company background image
BNXT logo

BioNxt Solutions CNSX:BNXT Stock Report

Last Price

CA$0.31

Market Cap

CA$35.2m

7D

-3.1%

1Y

-43.6%

Updated

22 Dec, 2024

Data

Company Financials

BNXT Stock Overview

Engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. More details

BNXT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

BioNxt Solutions Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BioNxt Solutions
Historical stock prices
Current Share PriceCA$0.31
52 Week HighCA$0.75
52 Week LowCA$0.17
Beta0.66
1 Month Change19.23%
3 Month Change55.00%
1 Year Change-43.64%
3 Year Change-74.17%
5 Year Change-69.61%
Change since IPO-69.00%

Recent News & Updates

Recent updates

Why We Think BioNxt Solutions Inc.'s (CSE:BNXT) CEO Compensation Is Not Excessive At All

Oct 27
Why We Think BioNxt Solutions Inc.'s (CSE:BNXT) CEO Compensation Is Not Excessive At All

BioNxt Solutions (CSE:BNXT) Is Making Moderate Use Of Debt

Nov 30
BioNxt Solutions (CSE:BNXT) Is Making Moderate Use Of Debt

Is XPhyto Therapeutics (CSE:XPHY) A Risky Investment?

Aug 03
Is XPhyto Therapeutics (CSE:XPHY) A Risky Investment?

Shareholder Returns

BNXTCA PharmaceuticalsCA Market
7D-3.1%-0.5%-2.6%
1Y-43.6%-26.7%15.2%

Return vs Industry: BNXT underperformed the Canadian Pharmaceuticals industry which returned -26.7% over the past year.

Return vs Market: BNXT underperformed the Canadian Market which returned 15.2% over the past year.

Price Volatility

Is BNXT's price volatile compared to industry and market?
BNXT volatility
BNXT Average Weekly Movement11.1%
Pharmaceuticals Industry Average Movement12.0%
Market Average Movement8.2%
10% most volatile stocks in CA Market17.4%
10% least volatile stocks in CA Market2.9%

Stable Share Price: BNXT has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatility Over Time: BNXT's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/aWolfgang Probstwww.bionxt.com

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022.

BioNxt Solutions Inc. Fundamentals Summary

How do BioNxt Solutions's earnings and revenue compare to its market cap?
BNXT fundamental statistics
Market capCA$35.15m
Earnings (TTM)-CA$6.48m
Revenue (TTM)CA$42.01k

836.9x

P/S Ratio

-5.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BNXT income statement (TTM)
RevenueCA$42.01k
Cost of RevenueCA$0
Gross ProfitCA$42.01k
Other ExpensesCA$6.52m
Earnings-CA$6.48m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.057
Gross Margin100.00%
Net Profit Margin-15,422.18%
Debt/Equity Ratio-76.0%

How did BNXT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:14
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioNxt Solutions Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution